Samuel Yang is a Senior Principal Scientist at Genentech, where they lead analytical projects across early development and clinical phases for small molecule and peptide therapeutics. With extensive experience in regulatory CMC filing and partnerships with contract manufacturing organizations, they have developed control strategies for clinical APIs and drug products. Samuel earned a Ph.D. in Chemistry (Analytical) from The University of Texas at Arlington and previously contributed as a Graduate Research Assistant there. Their career at Genentech also includes roles as an Associate Scientist and Senior Scientist, showcasing their expertise in analytical development and characterization of complex therapeutic compounds.
Location
San Francisco, United States